Media

NephroGenex Announces Closing of Initial Public Offering

Orexo receives million 5£ milestone payment for Abstral® in Europe and Zubsolv® continues strong market share growth in the US

Wilson Therapeutics secures $40 million private financing to advance late stage development program for Wilson disease

Topotarget and BioAlliance Pharma enter into merger agreement to create a leading orphan oncology company

OxThera closes new financing of EUR 8 million

Bonesupport reports positive data for CERAMENT™|G

Aerocrine resumes sales and marketing of NIOX MINO® in China after re-registration approval

Ultragenyx Announces Initiation of Phase 3 Study of Recombinant Human Beta-Glucuronidase in Mucopolysaccharidosis Type 7

Tengion Announces Continued Clinical Progress in Its Two Lead Programs

The Nexstim NBS device shows positive effects